Advertisement
Australia markets closed
  • ALL ORDS

    8,012.10
    +1.60 (+0.02%)
     
  • AUD/USD

    0.6672
    -0.0000 (-0.01%)
     
  • ASX 200

    7,769.40
    -0.30 (-0.00%)
     
  • OIL

    81.70
    +0.13 (+0.16%)
     
  • GOLD

    2,353.10
    +6.20 (+0.26%)
     
  • Bitcoin AUD

    99,311.25
    +1,685.79 (+1.73%)
     
  • CMC Crypto 200

    1,377.70
    -4.96 (-0.36%)
     

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc.

PRINCETON, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 11, 2024, at 4:00 p.m. E.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

ADVERTISEMENT

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G